Nurx
The compounder that publishes everything: concentrations, container volumes, prices, billing cadence and an explicit statement that its compounded products were never assessed by the FDA — all on the page you buy from. It is the disclosure standard the rest of this register has been asked for and refused.
MODEL
Online consultation, licensed provider review, pharmacy dispensing. Both single-agent generics at approved strengths and in-house compounded formulas. Medication shipped and billed every one, two or three months.
The brand verdict
One product family assessed so far, so this is a note rather than a pattern analysis, but it is the most consequential note in the brand register. Nurx does, unprompted and before purchase, what nine other telehealth companies here do not: it prints the concentration of every active, the volume of every container, the price, the billing cycle, and — on every compounded formula — the sentence 'It has not been FDA-approved or evaluated for safety, efficacy, or quality.'
It goes further than that. The spironolactone listing states that the drug is not FDA approved for acne and that the company in no way endorses that use, which is a piece of regulatory candour we have not seen elsewhere in this category. Insurance coverage is stated by indication, including which indications are not covered and why. Full prescribing information is linked for every single-agent product.
The single-agent generics alongside the compounds are the quiet argument. Tretinoin cream at three approved strengths in a 45 g tube, adapalene 0.3%, hydroquinone 4% in a 1 oz tube. For most people arriving wanting 'prescription skincare', one of those is the answer, and Nurx is the only service here that lets you see the approved option next to the compounded one on the same screen.
The failure is a specific one. The Dark Spots Formula puts five actives in a 26 ml bottle including hydrocortisone 1% and kojic acid 6%, and states no duration, no review point and no stop date. The approved product built on the same three-drug logic is licensed short-term only, because of exactly that corticosteroid. Everything else on the page is exemplary, which makes the omission conspicuous rather than characteristic.
- Every active concentration printed on the product listing, before purchase.
- Every container volume published — 45 g, 26 ml, 1 oz, 86 ml.
- An explicit 'not FDA-approved or evaluated for safety, efficacy, or quality' statement on every compounded product.
- The spironolactone listing states it is not FDA approved for acne and that the company does not endorse that use.
- Single-agent generics at approved strengths offered alongside the compounds.
- Tretinoin offered at three strengths, all inside the trial range.
- Hydroquinone offered at 4%, the conventional prescription concentration.
- Insurance coverage stated by indication, including the indications it does not cover.
- Named side effects and links to full prescribing information on each listing.
- Billing cadence stated plainly: shipped and billed every one, two or three months.
The range
- R-432026-08-02
Prescription Skincare
TRETINOIN, REVIVERX, DARK SPOTS FORMULAEvery concentration, every container size, every price and an explicit statement that the compounded formulas are not FDA approved — all on the page you buy from. It is the disclosure standard this register has been asking nine other companies for. Now read what is in the Dark Spots Formula.
CONDITIONAL$30 PER MONTH
What repeats across the range
These are the findings a single review cannot make. Each one appears in more than one product, and each is drawn from the reviews above rather than from an impression of the brand.
- 01
The concentration is on the page you buy from
Azelaic acid 10%, niacinamide 4%, tretinoin 0.025/0.05/0.1%, in a 26 ml bottle, for $90 — visible without a consultation, without an account and without a help-centre search. This is the single thing this register has asked every telehealth company for, and Nurx is the first to simply do it.
- 02
The container size is published too, so the maths works
45 g tube, 26 ml bottle, 1 oz tube, 86 ml bottle. Cost per application is computable across the whole catalogue. Not one Musely product, not one Alloy product and few of Dermatica's allow the same calculation.
- 03
It states its own regulatory status
Every compounded product carries an explicit statement that it is not FDA approved or evaluated. Obagi, a manufactured product whose FDA listing carries the same disclaimer, does not print it. Nurx does, on a product it makes itself and sells directly.
- 04
And then a corticosteroid with no end date
The Dark Spots Formula contains hydrocortisone 1% alongside hydroquinone 4% and tretinoin 0.05%, sold in three-month billing blocks with no stated duration. A three-month billing block is not a three-month course. The approved equivalent says to stop when control is achieved; this page says nothing.
- 05
One active in the range has no business being there
Kojic acid at 6% has no approved dermatological indication, a thin trial base and a recognised contact sensitisation risk, in a formula that already contains the best-evidenced depigmenting agent available. Publishing the number is good. The number is still unsupported.
Disclosure scorecard
Not what is in the product — what the company publishes about it, and where. “Findable” means the concentration exists somewhere, such as a help-centre article, rather than on the page you buy from.
SCROLL THE TABLE SIDEWAYS
| PRODUCT | CONC. ON PAGE | CONC. FINDABLE | CONTRA-INDICATIONS | SIZE | SIDE EFFECTS |
|---|---|---|---|---|---|
| Prescription Skincare | YES | YES | PART | YES | YES |
If you buy one
Prescription Skincare
Worth buying for a specific person with a specific problem. Read who.
Prescription Skincare
Worth buying for a specific person with a specific problem. Read who.